Table of Contents
Chapter 1 Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Formulation Segment
1.1.1.3. Sales Channel Segment
1.1.1.4. Consumer Group Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective 2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2 Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising consumer interest in active living
3.2.1.2. Increasing disposable income
3.2.1.3. Easy accessibility of nutrition and supplements
3.2.2. Market Restraint Analysis
3.2.2.1. Sale of counterfeit products in the market
3.2.3. Market Challenge Analysis
3.2.3.1. Changes in regulatory scenario
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4 Product Business Analysis
4.1. Latin America Nutritional Supplements Market: Product Movement Analysis
4.2. Sports Nutrition
4.2.1. Sports Nutrition Market, 2018 – 2030 (USD Million)
4.2.2. Sports Supplements
4.2.2.1. Sports supplements market estimates and forecasts, 2018 – 2030 (USD Million)
4.2.2.2. Protein Supplements
4.2.2.2.1. Protein Supplements Market, 2018 – 2030 (USD Million)
4.2.2.2.2. Egg Protein
4.2.2.2.2.1. Egg Protein Market, 2018 – 2030 (USD Million)
4.2.2.2.3. Soy Protein
4.2.2.2.3.1. Soy Protein Market, 2018 – 2030 (USD Million)
4.2.2.2.4. Pea Protein
4.2.2.2.4.1. Pea Protein Market, 2018 – 2030 (USD Million)
4.2.2.2.5. Lentil Protein
4.2.2.2.5.1. Lentil Protein Market, 2018 – 2030 (USD Million)
4.2.2.2.6. Hemp Protein
4.2.2.2.6.1. Hemp Protein Market, 2018 – 2030 (USD Million)
4.2.2.2.7. Casein
4.2.2.2.7.1. Casein Market, 2018 – 2030 (USD Million)
4.2.2.2.8. Quinoa Protein
4.2.2.2.8.1. Quinoa Protein Market, 2018 – 2030 (USD Million)
4.2.2.2.9. Whey Protein
4.2.2.2.9.1. Whey Protein Market, 2018 – 2030 (USD Million)
4.2.2.2.9.2. Whey Protein Isolate
4.2.2.2.9.2.1. Whey Protein Isolate Market, 2018 – 2030 (USD Million)
4.2.2.2.9.3. Whey Protein Concentrate
4.2.2.2.9.3.1. Whey Protein Concentrate Market, 2018 – 2030 (USD Million)
4.2.2.3. Vitamins
4.2.2.3.1. Vitamins Market, 2018 – 2030 (USD Million)
4.2.2.4. Minerals
4.2.2.4.1. Minerals Market, 2018 – 2030 (USD Million)
4.2.2.4.2. Calcium
4.2.2.4.2.1. Calcium Market, 2018 – 2030 (USD Million)
4.2.2.4.3. Potassium
4.2.2.4.3.1. Potassium Market, 2018 – 2030 (USD Million)
4.2.2.4.4. Magnesium
4.2.2.4.4.1. Magnesium Market, 2018 – 2030 (USD Million)
4.2.2.4.5. Iron
4.2.2.4.5.1. Iron Market, 2018 – 2030 (USD Million)
4.2.2.4.6. Zinc
4.2.2.4.6.1. Zinc Market, 2018 – 2030 (USD Million)
4.2.2.5. Amino Acids
4.2.2.5.1. Amino Acids Market, 2018 – 2030 (USD Million)
4.2.2.5.2. BCAA
4.2.2.5.2.1. BCAA Market, 2018 – 2030 (USD Million)
4.2.2.5.3. Arginine
4.2.2.5.3.1. Arginine Market, 2018 – 2030 (USD Million)
4.2.2.5.4. Aspartate
4.2.2.5.4.1. Aspartate Market, 2018 – 2030 (USD Million)
4.2.2.5.5. Glutamine
4.2.2.5.5.1. Glutamine Market, 2018 – 2030 (USD Million)
4.2.2.5.6. Beta Alanine
4.2.2.5.6.1. Beta alanine Market, 2018 – 2030 (USD Million)
4.2.2.5.7. Creatine
4.2.2.5.7.1. Creatine Market, 2018 – 2030 (USD Million)
4.2.2.5.8. L-carnitine
4.2.2.5.8.1. L-carnitine Market, 2018 – 2030 (USD Million)
4.2.2.6. Probiotics
4.2.2.6.1. Probiotics Market, 2018 – 2030 (USD Million)
4.2.2.7. Omega-3 Fatty Acids
4.2.2.7.1. Omega-3 Fatty Acids Market, 2018 – 2030 (USD Million)
4.2.2.8. Carbohydrates
4.2.2.8.1. Carbohydrates Market, 2018 – 2030 (USD Million)
4.2.2.8.2. Maltodextrin
4.2.2.8.2.1. Maltodextrin Market, 2018 – 2030 (USD Million)
4.2.2.8.3. Dextrose
4.2.2.8.3.1. Dextrose Market, 2018 – 2030 (USD Million)
4.2.2.9. Detox Supplements
4.2.2.9.1. Detox Supplements Market, 2018 – 2030 (USD Million)
4.2.2.10. Electrolytes
4.2.2.10.1. Electrolytes Market, 2018 – 2030 (USD Million)
4.2.2.11. Others
4.2.2.11.1. Others Market, 2018 – 2030 (USD Million)
4.2.3. Sports Drinks
4.2.3.1. Sports Drinks Market, 2018 – 2030 (USD Million)
4.2.3.2. Isotonic
4.2.3.2.1. Isotonic Market, 2018 – 2030 (USD Million)
4.2.3.3. Hypotonic
4.2.3.3.1. Hypotonic Market, 2018 – 2030 (USD Million)
4.2.3.4. Hypertonic
4.2.3.4.1. Hypertonic Market, 2018 – 2030 (USD Million)
4.2.4. Sports Foods
4.2.4.1. Sports Foods Market, 2018 – 2030 (USD Million)
4.2.4.2. Protein Bars
4.2.4.2.1. Protein Bars Market, 2018 – 2030 (USD Million)
4.2.4.3. Energy Bars
4.2.4.3.1. Energy Bars Market, 2018 – 2030 (USD Million)
4.2.4.4. Protein Gel
4.2.4.4.1. Protein Gel Market, 2018 – 2030 (USD Million)
4.2.5. Meal Replacement Products
4.2.5.1. Meal Replacement Products Market, 2018 – 2030 (USD Million)
4.2.6. Weight Loss Product
4.2.6.1. Weight Loss Product Market, 2018 – 2030 (USD Million)
4.3. Fat Burners
4.3.1. Fat Burners Market, 2018 – 2030 (USD Million)
4.3.2. Green Tea
4.3.2.1. Green Tea Market, 2018 – 2030 (USD Million)
4.3.3. Fiber
4.3.3.1. Fiber Market, 2018 – 2030 (USD Million)
4.3.4. Protein
4.3.4.1. Protein Market, 2018 – 2030 (USD Million)
4.3.5. Green Coffee
4.3.5.1. Green Coffee Market, 2018 – 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market, 2018 – 2030 (USD Million)
4.4. Dietary Supplements
4.4.1. Dietary Supplements Market, 2018 – 2030 (USD Million)
4.4.2. Vitamins
4.4.2.1. Vitamins Market, 2018 – 2030 (USD Million)
4.4.2.2. Multivitamin
4.4.2.2.1. Multivitamin Market, 2018 – 2030 (USD Million)
4.4.2.3. Vitamin A
4.4.2.3.1. Vitamin A Market, 2018 – 2030 (USD Million)
4.4.2.4. Vitamin B
4.4.2.4.1. Vitamin B Market, 2018 – 2030 (USD Million)
4.4.2.5. Vitamin C
4.4.2.5.1. Vitamin C Market, 2018 – 2030 (USD Million)
4.4.2.6. Vitamin D
4.4.2.6.1. Vitamin D Market, 2018 – 2030 (USD Million)
4.4.2.7. Vitamin E
4.4.2.7.1. Vitamin E Market, 2018 – 2030 (USD Million)
4.4.3. Minerals
4.4.3.1. Minerals Market, 2018 – 2030 (USD Million)
4.4.4. Enzymes
4.4.4.1. Enzymes Market, 2018 – 2030 (USD Million)
4.4.5. Amino Acids
4.4.5.1. Amino Acids Market, 2018 – 2030 (USD Million)
4.4.6. Conjugated Linoleic Acids
4.4.6.1. Conjugated Linoleic Acids Market, 2018 – 2030 (USD Million)
4.4.7. Others
4.4.7.1. Others Market, 2018 – 2030 (USD Million)
4.5. Functional Foods and Beverages
4.5.1. Functional Foods And Beverages Market, 2018 – 2030 (USD Million)
4.5.2. Probiotics
4.5.2.1. Probiotics Market, 2018 – 2030 (USD Million)
4.5.3. Omega-3
4.5.3.1. Omega-3 Market, 2018 – 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5 Formulation Business Analysis
5.1. Latin America Nutritional Supplements Market: Formulation Movement Analysis
5.2. Tablets
5.2.1. Tablets Market, 2018 – 2030 (USD Million)
5.3. Capsules
5.3.1. Capsules Market, 2018 – 2030 (USD Million)
5.4. Powder
5.4.1. Powder Market, 2018 – 2030 (USD Million)
5.5. Softgels
5.5.1. Softgels Market, 2018 – 2030 (USD Million)
5.6. Liquid
5.6.1. Liquid Market, 2018 – 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6 Sales Channel Business Analysis
6.1. Latin America Nutritional Supplements Market: Sales Channel Movement Analysis
6.2. Brick & Mortar
6.2.1. Brick & Mortar Market, 2018 – 2030 (USD Million)
6.2.2. Direct Selling
6.2.2.1. Direct selling market, 2018 – 2030 (USD Million)
6.2.3. Chemist/Pharmacies
6.2.3.1. Chemist/pharmacies market, 2018 – 2030 (USD Million)
6.2.4. Health Food Shops
6.2.4.1. Health food shops market, 2018 – 2030 (USD Million)
6.2.5. Hyper Markets
6.2.5.1. Hypermarkets market, 2018 – 2030 (USD Million)
6.2.6. Super Markets
6.2.6.1. Supermarkets market, 2018 – 2030 (USD Million)
6.3. E-commerce
6.3.1. E-Commerce Market, 2018 – 2030 (USD Million)
Chapter 7 Consumer Group Business Analysis
7.1. Latin America Nutritional Supplements Market: Consumer Group Movement Analysis
7.2. Infants
7.2.1. Infants Market, 2018 – 2030 (USD Million)
7.3. Children
7.3.1. Children Market, 2018 – 2030 (USD Million)
7.4. Adults
7.4.1. Adults Market, 2018 – 2030 (USD Million)
7.4.2. Age Group 21 – 30
7.4.2.1. Age Group 21-30 Market, 2018 – 2030 (USD Million)
7.4.3. Age Group 31-40
7.4.3.1. Age Group 31-40 Market, 2018 – 2030 (USD Million)
7.4.4. Age Group 4 -50
7.4.4.1. Age Group 41-50 Market, 2018 – 2030 (USD Million)
7.4.5. Age Group 51-65
7.4.5.1. Age Group 51-65 Market, 2018 – 2030 (USD Million)
7.5. Geriatric
7.5.1. Geriatric Market, 2018 – 2030 (USD Million)
7.6. Pregnant
7.6.1. Pregnant Market, 2018 – 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1. Latin America Nutritional Supplements Market Share By Region, 2022 & 2030
8.2. Latin America
8.2.1. Latin America Nutritional Supplements Market, 2018 – 2030 (USD Million)
8.2.2. Brazil
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. Brazil Nutritional Supplements Market, 2018 – 2030 (USD Million)
8.2.3. Mexico
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Mexico Nutritional Supplements Market, 2018 – 2030 (USD Million)
8.2.4. Argentina
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Argentina Nutritional Supplements Market, 2018 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share/Positioning Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Herbalife International of America, Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Amway International
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Bayer AG
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Sanofi
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Abbott
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Nestle
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Pfizer, Inc.
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. GNC Holdings, Inc.
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Ground & Pound Supplements
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/